Biology Reference
In-Depth Information
Lecaille F, Choe Y, Brandt W, Li Z, Craik CS, Bromme D (2002a) Selective inhibition of the
collagenolytic activity of human cathepsin K by altering its S2 subsite specificity. Biochemis-
try 41:8447-8454
Lecaille F, Kaleta J, Bromme D (2002b) Human and parasitic papain-like cysteine proteases: their
role in physiology and pathology and recent developments in inhibitor design. Chem Rev
102:4459-4488
Levicar N, Strojnik T, Kos J, Dewey RA, Pilkington GJ, Lah TT (2002) Lysosomal enzymes,
cathepsins in brain tumour invasion. J Neurooncol 58:21-32
Li Z, Hou WS, Bromme D (2000) Collagenolytic activity of cathepsin K is specifically modulated
by cartilage-resident chondroitin sulfates. Biochemistry 39:529-536
Li Z, Hou WS, Escalante-Torres CR, Gelb BD, Bromme D (2002) Collagenase activity of
cathepsin K depends on complex formation with chondroitin sulfate. J Biol Chem
277:28669-28676
Li Z, Yasuda Y, Li W, Bogyo M, Katz N, Gordon RE, Fields GB, Bromme D (2004) Regulation of
collagenase activities of human cathepsins by glycosaminoglycans. J Biol Chem 279:5470-5479
Li Z, Kienetz M, Cherney MM, James MN, Bromme D (2008) The crystal and molecular
structures of a cathepsin K:chondroitin sulfate complex. J Mol Biol 383:78-91
Lijnen HR (2003) Metalloproteinases in development and progression of vascular disease. Patho-
physiol Haemost Thromb 33:275-281
Linnevers C, Smeekens SP, Bromme D (1997) Human cathepsin W, a putative cysteine protease
predominantly expressed in CD8+ T-lymphocytes. FEBS Lett 405:253-259
Littlewood-Evans A, Kokubo T, Ishibashi O, Inaoka T, Wlodarski B, Gallagher JA, Bilbe G
(1997) Localization of cathepsin K in human osteoclasts by in situ hybridization and immu-
nohistochemistry. Bone 20:81-86
Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP (2004) Lysosomal cysteine proteases in
atherosclerosis. Arterioscler Thromb Vasc Biol 24:1359-1366
Lutgens E, Lutgens SP, Faber BC, Heeneman S, Gijbels MM, de Winther MP, Frederik P, van der
Made I, Daugherty A, Sijbers AM, Fisher A, Long CJ, Saftig P, Black D, Daemen MJ, Cleutjens
KB (2006) Disruption of the cathepsin K gene reduces atherosclerosis progression and induces
plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113:98-107
Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S (2007) Cathepsin cysteine proteases in
cardiovascular disease. FASEB J 21:3029-3041
Maciewicz RA, Etherington DJ (1988) A comparison of four cathepsins (B, L, N, and S) with
collagenolytic activity from rabbit spleen. Biochem J 256:433-440
Maciewicz RA, Wotton SF (1991) Degradation of cartilage matrix components by the cysteine
proteinases, cathepsins B and L. Biomed Biochim Acta 50:561-564
Maciewicz RA, Wotton SF, Etherington DJ, Duance VC (1990) Susceptibility of the cartilage
collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L.
FEBS Lett 269:189-193
Mai J, Waisman DM, Sloane BF (2000) Cell surface complex of cathepsin B/annexin II tetramer in
malignant progression. Biochim Biophys Acta 1477:215-230
Mai J, Sameni M, Mikkelsen T, Sloane BF (2002) Degradation of extracellular matrix protein
tenascin-C by cathepsin B: an interaction involved in the progression of gliomas. Biol Chem
383:1407-1413
Mason RW (2008) Emerging functions of placental cathepsins. Placenta 29:385-390
Mason RW, Massey SD (1992) Surface activation of pro-cathepsin L. Biochem Biophys Res
Commun 189:1659-1666
Mason RW, Johnson DA, Barrett AJ, Chapman HA (1986) Elastinolytic activity of human
cathepsin L. Biochem J 233:925-927
Mason RW, Gal S, Gottesman MM (1987) The identification of the major excreted protein (MEP)
from a transformed mouse fibroblast cell line as a catalytically active precursor form of
cathepsin L. Biochem J 248:449-454
